Logo
smart post preloader
Milestone on the Path towards Clinical Approval for a Potential New Therapy for Resistant Hypertension

Milestone on the Path towards Clinical Approval for a Potential New Therapy for Resistant Hypertension

The start of the baroloop Multi-Center Trial (MCT) marks an important milestone on the path toward clinical approval. Across several European centers, the study will evaluate the efficacy and safety …

WEITERLESEN
FDA Grants “Breakthrough Device Designation” for VNS Stimulation System

FDA Grants “Breakthrough Device Designation” for VNS Stimulation System

On October 30, 2023, the FDA granted Breakthrough Device Designation to our vagus nerve stimulation system baroloop. Since January 31, 2024, neuroloop has also been participating in the FDA’s Total …

WEITERLESEN